Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.23
-0.44 (-1.71%)
At close: Oct 6, 2026, 4:00 PM EDT
24.89
-0.34 (-1.35%)
Pre-market: Oct 7, 2026, 7:02 AM EDT

Beam Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,5212,7361,9742,1592,6925,327
Market Cap Growth
-0.38%38.60%-8.58%-19.78%-49.47%15.54%
Enterprise Value
1,6161,8121,2101,3181,7764,539
Last Close Price
25.2327.7224.8027.2239.1179.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
16.1619.5831.085.7244.18102.75
PB Ratio
2.362.212.692.203.676.44
P/TBV Ratio
2.362.212.692.203.676.44
P/OCF Ratio
----119.48-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
10.3512.9719.053.4929.1587.56

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.230.120.220.180.250.18
Net Debt / Equity Ratio
-0.85-0.88-0.94-1.04-1.22-0.99
Net Debt / EBITDA Ratio
2.553.021.756.502.773.56
Net Debt / FCF Ratio
2.433.031.945.5633.967.23
Asset Turnover
0.110.110.050.270.040.05
Quick Ratio
14.2512.854.675.794.825.93
Current Ratio
14.5713.094.825.894.895.96
Return on Equity (ROE)
-8.18%-8.11%-43.94%-15.46%-37.06%-69.13%
Return on Assets (ROA)
-17.01%-18.55%-20.26%-7.88%-15.02%-15.41%
Return on Capital Employed (ROCE)
-29.00%-27.70%-45.10%-14.10%-30.30%-18.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.43%-2.92%-19.09%-6.14%-10.74%-6.96%
FCF Yield
-14.79%-13.16%-18.05%-8.47%-0.98%-2.12%
Buyback Yield / Dilution
-16.29%-20.16%-6.69%-10.19%-9.01%-37.44%
SEC Filings: 10-K · 10-Q